Consultation: Updated Definition of Health Technology Assessment

A joint task group headed by the International Network of Agencies for Health Technology Assessment (INAHTA) and Health Technology Assessment international (HTAi) with support from representatives including the European Network for Health Technology Assessment (EUnetHTA) is preparing a proposal to revise the definition of health technology assessment (HTA). The joint task group aims to build a broad consensus on the definition of HTA. The consultation is inviting members from the HTA community to submit comments in writing.

According to the consultation page:

“HTA is currently defined as:

“A multidisciplinary process that uses explicit and scientifically robust methods to assess the value of using a health technology at different points in its lifecycle. The process is comparative, systematic, transparent and involves multiple stakeholders. The purpose is to inform health policy and decision-making to promote an efficient, sustainable, equitable and high-quality health system.

“Note 1: A health technology is an intervention, health product or service developed to prevent, diagnose or treat medical conditions; promote health; provide rehabilitation; or organise healthcare delivery. The intervention can be a test, device, medicine, vaccine, procedure, program or system.

“Note 2: The dimensions of value for a health technology may be assessed by examining its clinical effectiveness and safety, costs and economic implications, wider implications for the patient and caregivers, and any ethical, social, cultural, or legal issues, as well as organisational and environmental aspects. The overall value may vary depending on the perspective taken, and the decision context.

“Note 3: HTA is a process that may include several activities related to the lifecycle of a health technology. This comprises identification (e.g. horizon scanning), prioritisation of what to assess, assessment (evaluation of effects and impacts), appraisal (determining overall value), and implementation and monitoring (e.g. re-assessment).”

The consultation is open until 30th April 2019. Find out more here.

For more consultations please see MAP’s consultation tracker here.

Tagged with

Published on 11. April 2019 in News, News EU